Changes in insight during treatment for psychotic disorders: A meta-analysis

Schizophrenia Research

Volumn 144, Issue 1-3, 2013, Pages 109-117

  Pijnenborg, Gerdina H M ^a,b,c   Van Donkersgoed, Rozanne J M ^a   David, Anthony S ^d   Aleman, André ^b,c  

^a GGZ Drenthe ^*  (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Awareness; Insight; Meta analysis; Psychosis; Schizophrenia; Treatment

Indexed keywords

HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE;

AWARENESS; COGNITIVE THERAPY; DEPRESSION; EFFECT SIZE; HEALTH EDUCATION; HUMAN; INTROSPECTION; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOEDUCATION; PSYCHOSIS; PSYCHOTHERAPY; QUALITY OF LIFE; REVIEW; SEX DIFFERENCE; SYSTEMATIC REVIEW;

AWARENESS; DEPRESSION; HUMANS; PSYCHOTHERAPY; PSYCHOTIC DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCHIZOPHRENIA; SELF CONCEPT; VALIDATION STUDIES AS TOPIC;

EID: 84873526459     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.11.018     Document Type: Review

References (53)

1. Amador X.F., Strauss D.H., Yale S.A., Flaum M.M., Endicott J., Gorman J.M. Assessment of insight in psychosis. Am. J. Psychiatry 1993, 150:873-879.
2. Ascher-Svanum H., Whitesel J. A randomized controlled study of two styles of group patient education about schizophrenia. Psychiatr. Serv. 1999, 50:926-930.
3. Beck A.T., Baruch E., Balter J.M., Steer R.A., Warman D.M. A new instrument for measuring insight: the Beck Cognitive Insight Scale. Schizophr. Res. 2004, 68:319-329.
4. Birchwood M., Smith J., Drury V., Healy J., Macmillan F., Slade M.A. Self report Insight Scale for psychosis: reliability, validity and sensitivity to change. Acta Psychiatr. Scand. 1994, 89:62-67.
5. Carroll A., Fattah S., Clyde Z., Coffey I., Owens D.G.C., Johnstone E.C. Correlates of insight and insight change in schizophrenia. Schizophr. Res. 1998, 35:247-253.
6. Chan S.H., Lee S.W., Chan I.W. TRIP: a psycho-educational programme in Hong Kong for people with schizophrenia. Occup. Ther. Int. 2007, 14(2):86-98.
7. Chan S.W., Yip B., Tso S., Cheng B., Tame W. Evaluation of a psychoeducation program for Chinese clients with schizophrenia and their family caregivers. Patient Educ. Couns. 2009, 75:67-76.
8. Cunnigham-Owens D.G., Carroll A., Fattah S., Clyde Z., Coffey E., Johnstone E.C. A randomized, controlled trial of a brief interventional package for schizophrenic outpatients. Acta Psychiatr. Scand. 2001, 103:362-369.
9. Dam J. Insight in schizophrenia: a review. Nord. J. Psychiatry 2006, 60:114-120.
10. David A.S. Insight and psychosis. Br. J. Psychiatry 1990, 156:789-809.
11. David A.S. The clinical importance of insight: an overview. Insight and Psychosis 2004, Oxford University Press, Oxford. X.F. Amador, A.S. David (Eds.).
12. David A.S., Ster I.C., Zavarei H. Effect of video self versus other observation on insight in psychotic disorders. J. Nerv. Ment. Dis. 2012, 200(4):358-361.
13. Davidoff S.A., Forester B.P., Ghaemi S.N., Bodkin J.A. The effect of video self-observation on development of insight in psychotic disorders. J. Nerv. Ment. Dis. 1998, 186(11):697-700.
14. Drake R.J., Dunn G., Tarrier N., Bentall R.P., Haddock G., Lewis S.W. Insight as a predictor of the outcome of first-episode nonaffective psychosis in a prospective cohort study in England. J. Clin. Psychiatry 2007, 68:81-86.
15. Drury V., Birchwood M., Cochrane R. Cognitive therapy and recovery from acute psychosis: a controlled trial. 3. Five-year follow-up. Br. J. Psychiatry 2000, 177:8-14.
16. Emmerson L.C., Granholm E., Link P.C., McQuaid J.R., Jeste D.V. Insight and treatment outcome with cognitive behavioral social skills training for older people with schizophrenia. J. Rehabil. Res. Dev. 2009, 46(8):1053-1058.
17. Favrod J., Maire A., Bardy S., Pernier S., Bonsack C. Improving insight into delusions: a pilot study of metacognitive training for patients with schizophrenia. J. Adv. Nurs. 2011, 67(2):401-407.
18. Fung K.M.T., Tsang H.W.H., Cheung W. Randomized controlled trial of the self-stigma reduction program amongst individuals with schizophrenia. Psychiatry Res. 2011, 189:208-214.
19. Garety P., Fowler D., Kuipers E., Freeman D., Dunn G., Bebbington P., Hadley C., Jones S. London-East Anglia randomized controlled trial for psychosis. II: Predictors of outcome. Br. J. Psychiatry 1997, 171:420-426.
20. Granholm E., McQuaid J.R., McClure F.S., Auslander L.A., Perivoliotis D., Pedrelli P., Patterson T., Jeste D.V. A randomised controlled trial of cognitive behavioral social skills training for middle-aged and older outpatients with chronic schizophrenia. Am. J. Psychiatry 2005, 162:520-529.
21. Granholm E., McQuaid J.R., McClure F.S., Link P.C., Perivoliotis D., Gottlieb J.D., Patterson T.L., Jeste D.V. Randomised controlled trial of cognitive behavioral social skills training for middle-aged and older outpatients with chronic schizophrenia: 12-month follow-up. J. Clin. Psychiatry 2007, 68:730-737.
22. Gray R., Leese M., Bindman J., Becker T., Burti L., David A., Gournay K., Kikkert M., Koeter M., Puschner B., Schene A., Thornicroft G., Tanselle M. Adherence therapy for people with schizophrenia. Br. J. Psychiatry 2006, 189:508-514.
23. Guo X., Zhai J., Zhening L., Maosheng F., Wang B., Wang C., Bin H., Sun X., Luxian L., Zheng L., Cui M., He X., Guo T., Xie S., Wu R., Xue Z., Chen J., Twamley E.W., Jin H., Zhao J. Effect of antipsychotic medication alone vs combined with psychosocial intervention on outcomes of early-stage schizophrenia. Arch. Gen. Psychiatry 2010, 67(9):895-904.
24. Haddock G., Lewis S., Bentall R., Dunn G., Drake R., Tarrier N. Influence of age on outcome of psychological treatments in first-episode psychosis. Br. J. Psychiatry 2006, 188:250-254.
25. Hayward P., David A.S., Green N., Rabe-Hesketh S., Haworth E., Thompson N., Shaffer S., Hastilow S., Wykes T. Promoting therapeutic alliance in clozapine users: an exploratory randomized controlled trial. Clin. Schizophr. Rel. Psychoses 2009, 3:127-132.
26. Henry C.S., Ghaemi N. Insight in psychosis: a systematic review of treatment interventions. Bipolar Disord. 2004, 37:194-199.
27. Jong-Hoon K., Jun-Hung A., Lee J. Insight change and its relationship to subjective well-being during acute atypical antipsychotic treatment in schizophrenia. J. Clin. Pharm. Ther. 2011, 36:687-694.
28. Kay S., Fiszbein A., Opler L. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13:261-276.
29. Kemp R., David A.T. Insight and compliance. Blackwell B. Treatment Compliance and the Therapeutic Alliance 1996, Gordon & Breach, Newark.
30. Kemp R., Kirov G., Everitt B., Hayward P., David A. A randomised controlled trial of compliance therapy: 18-month follow-up. Br. J. Psychiatry 1998, 172:413-419.
31. Liemburg E.J., Knegtering H., Klien H.C., Kortekaas R., Aleman A. Antipsychotic medication and prefrontal cortex activation: a review of neuroimaging findings. Eur. Neuropsychopharmacol. 2012, 22(6):387-400.
32. Lincoln T.M., Lullmann E., Rief W. Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review. Schizophr. Bull. 2007, 33:1324-1342.
33. Lipsey M.W., Wilson D.B. Practical Meta-Analysis 2000, SAGE publications, Thousand Oaks, California.
34. Macpherson R., Jerrom B., Hughes A. A controlled study of education about drug treatment in schizophrenia. Br. J. Psychiatry 1996, 168:709-717.
35. McEvoy J.P., Apperson J., Appelbaum P.S., Ortilip P., Brecosky J., Hammill K., Geller J.L., Roth L. Insight in schizophrenia: its relationship to acute psychopathology. J. Nerv. Ment. Dis. 1989, 17:43-47.
36. McEvoy J.P., Johnson J., Perkins D., Lieberman J.A., Hamer R.M., Keefe R.S.E., Tohen M., Glick I.D., Sharma T. Insight in first-episode psychosis. Psychol. Med. 2006, 36:1385-1393.
37. Merinder L.B., Viuff A.G., Laugesen H.D., Clemmensen K., Misfelt S., Espensen B. Patient and relative education in community psychiatry: a randomized controlled trial regarding its effectiveness. Soc. Psychiatry Psychiatr. Epidemiol. 1999, 34:287-294.
38. Mintz A.R., Dobson K.S., Romney D.M. Insight in schizophrenia: a meta-analysis. Schizophr. Res. 2003, 61(1):75-88.
39. Morris S.B. Estimating effect sizes from pretest-posttest-control group designs. Organ. Res. Methods 2008, 11(2):364-386.
40. O'Donnell C., Donohoe G., Sharkey L., Owens N., Migone M., Harries R., Kinsella A., Larkin C., O'Callaghan E. Compliance therapy: a randomised controlled trial in schizophrenia. Br. Med. J. 2003, 327:834-836.
41. Penn D.L., Meyer P.S., Evans E., Wirth R.J., Cai K., Burchinal M. Randomized controlled trial of group cognitive-behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophr. Res. 2009, 109:52-57.
42. Peters E., Landau S., McCrone P., Cooke M., Fisher P., Steel C., Evans R., Carswell K., Dawson K., Williams S., Howard A., Kuipers E. A randomised controlled trial of cognitive behaviour therapy for psychosis in a routine clinical service. Acta Psychiatr. Scand. 2010, 122:302-318.
43. Pijnenborg G.H.M., Vander Gaag M., Bockting C., Aleman A. REFLEX: a social-cognitive group treatment to improve insight in schizophrenia: study protocol of a multi-centre RCT. BMC Psychiatry 2011, 11:161.
44. Premkumar P., Peters E.R., Fannon D., Anilkumar A.P., Kuipers E., Kumari V. Coping styles predict responsiveness to cognitive behaviour therapy in psychosis. Psychiatry Res. 2011, 187(3):354-362.
45. Rathod S., Kingdon D., Smith P., Turkington D. Insight into schizophrenia: the effects of cognitive behavioural therapy on the components of insight and association with sociodemographics-data on a previously published randomised controlled trial. Schizophr. Res. 2005, 74:211-219.
46. Shad M.U., Muddasani S., Prasad K., Sweeney J.A., Keshavana M.S. Insight and prefrontal cortex in first-episode schizophrenia. NeuroImage 2004, 22(3):1315-1320.
47. Staring A.B.P., Van Der Gaag M., Van Den Berge M., Duivenvoorden H.J., Mulder C.L. Stigma moderates the associations of insight with depressed mood, low self-esteem and low quality of life in patients with schizophrenia spectrum disorders. Schizophr. Res. 2010, 115:363-369.
48. Stefanopoulou E., Lafuente A.R., Saez Fonseca J.A., Huxley A. Insight, global functioning and psychopathology amongst in-patient clients with schizophrenia. Psychiatr. Q. 2009, 80:155-165.
49. Turkington D., Kingdon D., Turner T. Effectiveness of a brief cognitive-behavioral therapy intervention in the treatment of schizophrenia. Br. J. Psychiatry 2002, 180:523-527.
50. Turkington D., Kingdon D., Rathod S., Hammond K., Pelton J., Metha R. Outcomes of an effectiveness trial of cognitive behavioural intervention by mental health nurses in schizophrenia. Br. J. Psychiatry 2006, 189:36-40.
51. Wiffen B.R.D., Rabinowitz J., Fleischhacker W.W., David A.S. Insight: demographic differences and associations with one-year outcome in schizophrenia and schizoaffective disorder. Clin. Schizophr. Relat. Psychoses 2010, 4(3):169-175.
52. Wilson D.B. Professional Development Course on Meta-analysis http://mason.gmu.edu/~dwilsonb/ma.html.
53. Xiang Y., Weng Y., Li W., Gao L., Chen G., Xie L., Chang Y., Tang W., Ungvari G.S. Efficacy of the Community Re-Entry Module for patients with schizophrenia in Beijing, China: outcome at 2-year follow-up. Br. J. Psychiatry 2007, 190:49-56.